SANGAMO THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $21.7M | $157.9M | $22.1M |
| FY2017 | $98.8M | $286.7M | $49.8M |
| FY2018 | $223.1M | $590.4M | $140.4M |
| FY2019 | $204.8M | $637.5M | $80.4M |
| FY2020 | $441.2M | $938.6M | $131.3M |
| FY2021 | $346.6M | $721.9M | $178.9M |
| FY2022 | $267.6M | $562.5M | $100.4M |
| FY2023 | $82.4M | $165.3M | $45.2M |
| FY2024 | $78.9M | $101.6M | $41.9M |
| FY2025 | $74.0M | $59.7M | $20.9M |